A Pharmacokinetic and Pharmacodynamic Study of Two Formulations of Omega-3 One Gram Capsules After Single and Multi-Dose Administrations Under Fed Conditions
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 03 Mar 2017
At a glance
- Drugs MAT 9001 (Primary) ; Antihyperlipidaemics
- Indications Dyslipidaemias; Hypertriglyceridaemia
- Focus First in man; Pharmacokinetics
- Sponsors Matinas BioPharma
- 15 Jun 2015 PK/PD trial data presented at the National Lipid Association (NLA) Scientific Sessions, as per Matinas BioPharma media release.
- 15 Jun 2015 PK/PD results published in the Media Release.
- 04 Jun 2015 Additional data will be presented at the National Lipid Association (NLA) Scientific Sessions, as per Matinas BioPharma media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History